Cargando…
Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient
Autores principales: | Rafat, Shamim, Sandeep, Sahu, Tasneem, Siddiqui, Sanjay, Agarwal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672510/ https://www.ncbi.nlm.nih.gov/pubmed/29109655 http://dx.doi.org/10.4103/joacp.JOACP_128_16 |
Ejemplares similares
-
Antithymocyte Globulin: Indiscriminate Use and Complications
por: Khan, Taqi, et al.
Publicado: (2019) -
A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients
por: Schweiger, Martin, et al.
Publicado: (2018) -
Rabbit Antithymocyte Globulin Induction in Heart Transplant Recipients at High Risk for Rejection
por: Kitto, Brent, et al.
Publicado: (2021) -
Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020) -
Comparing the effect of induction therapy with or without antithymocyte globulin on renal allograft outcomes in live-donor kidney transplant recipients
por: Marghoob, Bahareh, et al.
Publicado: (2019)